SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015506
Filing Date
2018-11-09
Accepted
2018-11-08 18:31:26
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 683234
2 ex31-1.htm EX-31.1 9700
3 ex31-2.htm EX-31.2 9697
4 ex32-1.htm EX-32.1 7718
  Complete submission text file 0001493152-18-015506.txt   2972040

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20180930.xml EX-101.INS 410513
6 XBRL SCHEMA FILE cocp-20180930.xsd EX-101.SCH 40793
7 XBRL CALCULATION FILE cocp-20180930_cal.xml EX-101.CAL 43054
8 XBRL DEFINITION FILE cocp-20180930_def.xml EX-101.DEF 137218
9 XBRL LABEL FILE cocp-20180930_lab.xml EX-101.LAB 277143
10 XBRL PRESENTATION FILE cocp-20180930_pre.xml EX-101.PRE 207373
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 181170972
SIC: 2834 Pharmaceutical Preparations